BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27188391)

  • 1. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines.
    Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL
    Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7 Methyl indole ethyl isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells.
    Kristjansdottir K; Kim K; Choi JS; Horan TC; Brard L; Moore RG; Singh RK
    Gynecol Oncol; 2012 Aug; 126(2):252-8. PubMed ID: 22561404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
    Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
    Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and
    Roque DR; Zhang L; Wysham WZ; Han J; Sun W; Yin Y; Livingston JN; Batchelor KW; Zhou C; Bae-Jump VL
    Front Oncol; 2021; 11():690435. PubMed ID: 34422646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells.
    Wright C; Iyer AKV; Kaushik V; Azad N
    J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amentoflavone promotes ferroptosis by regulating reactive oxygen species (ROS) /5'AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) to inhibit the malignant progression of endometrial carcinoma cells.
    Sun Q; Zhen P; Li D; Liu X; Ding X; Liu H
    Bioengineered; 2022 May; 13(5):13269-13279. PubMed ID: 35635082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
    Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
    Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
    Kilgore J; Jackson AL; Clark LH; Guo H; Zhang L; Jones HM; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Am J Transl Res; 2016; 8(6):2705-15. PubMed ID: 27398153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
    Sankaranarayanapillai M; Zhang N; Baggerly KA; Gelovani JG
    Mol Imaging Biol; 2013 Apr; 15(2):136-47. PubMed ID: 22886728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.
    Han J; Zhang L; Guo H; Wysham WZ; Roque DR; Willson AK; Sheng X; Zhou C; Bae-Jump VL
    Gynecol Oncol; 2015 Sep; 138(3):668-75. PubMed ID: 26135947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
    Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
    Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orlistat treatment induces apoptosis and arrests cell cycle in HSC-3 oral cancer cells.
    Xiao X; Liu H; Li X
    Microb Pathog; 2017 Nov; 112():15-19. PubMed ID: 28882785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glutaminase Inhibitor Compound 968 Exhibits Potent
    Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
    Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines.
    Hill TK; Davis AL; Wheeler FB; Kelkar SS; Freund EC; Lowther WT; Kridel SJ; Mohs AM
    Mol Pharm; 2016 Mar; 13(3):720-8. PubMed ID: 26824142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
    Xinxin H; Meng Z; Guiyu Z
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endometrial cancer cell lines by mifepristone (RU 486).
    Schneider CC; Gibb RK; Taylor DD; Wan T; Gerçel-Taylor C
    J Soc Gynecol Investig; 1998; 5(6):334-8. PubMed ID: 9824816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.